BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1027 related articles for article (PubMed ID: 25703562)

  • 1. Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis.
    Hmama Z; Peña-Díaz S; Joseph S; Av-Gay Y
    Immunol Rev; 2015 Mar; 264(1):220-32. PubMed ID: 25703562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage defense mechanisms against intracellular bacteria.
    Weiss G; Schaible UE
    Immunol Rev; 2015 Mar; 264(1):182-203. PubMed ID: 25703560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-species communication in the Mycobacterium tuberculosis-infected macrophage.
    Tan S; Russell DG
    Immunol Rev; 2015 Mar; 264(1):233-48. PubMed ID: 25703563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage takeover and the host-bacilli interplay during tuberculosis.
    Hussain Bhat K; Mukhopadhyay S
    Future Microbiol; 2015; 10(5):853-72. PubMed ID: 26000654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis and the art of macrophage manipulation.
    Upadhyay S; Mittal E; Philips JA
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29762680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Interferes with Mycobacterium tuberculosis Antigen Presentation in Human Dendritic Cells.
    Singh SK; Andersson AM; Ellegård R; Lindestam Arlehamn CS; Sette A; Larsson M; Stendahl O; Blomgran R
    Am J Pathol; 2016 Dec; 186(12):3083-3093. PubMed ID: 27746182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.
    Noss EH; Pai RK; Sellati TJ; Radolf JD; Belisle J; Golenbock DT; Boom WH; Harding CV
    J Immunol; 2001 Jul; 167(2):910-8. PubMed ID: 11441098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Analysis of Human Macrophage Inflammatory Response Related to
    Bade P; Simonetti F; Sans S; Laboudie P; Kissane K; Chappat N; Lagrange S; Apparailly F; Roubert C; Duroux-Richard I
    Front Immunol; 2021; 12():668060. PubMed ID: 34276658
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protective immunity against Mycobacterium tuberculosis].
    Kawamura I
    Kekkaku; 2006 Nov; 81(11):687-91. PubMed ID: 17154048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection.
    Giraud-Gatineau A; Coya JM; Maure A; Biton A; Thomson M; Bernard EM; Marrec J; Gutierrez MG; Larrouy-Maumus G; Brosch R; Gicquel B; Tailleux L
    Elife; 2020 May; 9():. PubMed ID: 32369020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis.
    Rovetta AI; Peña D; Hernández Del Pino RE; Recalde GM; Pellegrini J; Bigi F; Musella RM; Palmero DJ; Gutierrez M; Colombo MI; García VE
    Autophagy; 2014; 10(12):2109-21. PubMed ID: 25426782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell death and autophagy in tuberculosis.
    Moraco AH; Kornfeld H
    Semin Immunol; 2014 Dec; 26(6):497-511. PubMed ID: 25453227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to
    Lugo-Villarino G; Troegeler A; Balboa L; Lastrucci C; Duval C; Mercier I; Bénard A; Capilla F; Al Saati T; Poincloux R; Kondova I; Verreck FAW; Cougoule C; Maridonneau-Parini I; Sasiain MDC; Neyrolles O
    Front Immunol; 2018; 9():1123. PubMed ID: 29946317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity in tuberculosis: host defense vs pathogen evasion.
    Liu CH; Liu H; Ge B
    Cell Mol Immunol; 2017 Dec; 14(12):963-975. PubMed ID: 28890547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.
    Källenius G; Correia-Neves M; Buteme H; Hamasur B; Svenson SB
    Tuberculosis (Edinb); 2016 Jan; 96():120-30. PubMed ID: 26586646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?
    Berrington WR; Hawn TR
    Immunol Rev; 2007 Oct; 219():167-86. PubMed ID: 17850489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Transcriptional Foundations of Sp110-mediated Macrophage (RAW264.7) Resistance to Mycobacterium tuberculosis H37Ra.
    Wu Y; Guo Z; Yao K; Miao Y; Liang S; Liu F; Wang Y; Zhang Y
    Sci Rep; 2016 Feb; 6():22041. PubMed ID: 26912204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to tuberculosis--novel drugs based on drug targets related to toll-like receptors in macrophages.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4404-17. PubMed ID: 24245765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is targeting dysregulation in apoptosis splice variants in Mycobacterium tuberculosis (MTB) host interactions and splicing factors resulting in immune evasion by MTB strategies a possibility?
    Dlamini Z; Alaouna M; Cholo MC; Hull R
    Tuberculosis (Edinb); 2020 Sep; 124():101964. PubMed ID: 32829075
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Köster S; Upadhyay S; Chandra P; Papavinasasundaram K; Yang G; Hassan A; Grigsby SJ; Mittal E; Park HS; Jones V; Hsu FF; Jackson M; Sassetti CM; Philips JA
    Proc Natl Acad Sci U S A; 2017 Oct; 114(41):E8711-E8720. PubMed ID: 28973896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 52.